Detalhe da pesquisa
1.
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med
; 388(23): 2159-2170, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972022
2.
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
Gynecol Oncol
; 175: 176-181, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37393743
3.
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.
Gynecol Oncol
; 154(1): 183-188, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31104905
4.
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial.
J Clin Oncol
; 40(27): 3115-3119, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960897
5.
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.
J Clin Oncol
; 38(15): 1685-1692, 2020 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073955
6.
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.
J Clin Oncol
; 36(24): 2538-2544, 2018 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29989857
7.
Preclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer Treatment.
Clin Cancer Res
; 23(14): 3781-3793, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28167510